Risk of diabetes in the new diagnostic category of impaired fasting glucose: A prospective analysis

Diabetes Care

Volumn 22, Issue 9, 1999, Pages 1490-1493

  Vaccaro, Olga ^a   Ruffa, Gianluca ^a   Imperatore, Giuseppina ^a   Iovino, Vincenzo ^a   Rivellese, Angela Albarosa ^a   Riccardi, Gabriele ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; GLUCOSE OXIDASE;

ADULT; ARTICLE; DIABETES MELLITUS; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; IMPAIRED GLUCOSE TOLERANCE; MAJOR CLINICAL STUDY; MALE; ORAL GLUCOSE TOLERANCE TEST; PREVALENCE; RISK;

ADMINISTRATION, ORAL; ADULT; DISEASE PROGRESSION; FASTING; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HUMANS; ITALY; MIDDLE AGED; ODDS RATIO; PREVALENCE; RISK FACTORS;

EID: 0032841913     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.22.9.1490     Document Type: Article

References (24)

1. World Health Organization: Diabetes Mellitus: Report of a WHO Study Group. Geneva, World Health Org., 1980 (Tech. Rep. Ser., no. 646)
2. World Health Organization: Diabetes Mellitus: Report of a WHO Study Group. Geneva, World Health Org., 1985 (Tech. Rep. Ser., no. 727)
3. National Diabetes Data Group: Classification and diagnosis of diabetes mellitus and their categories of glucose intolerance. Diabetes 28:1039-1057, 1979
4. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus: Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 20:S5-S19, 1997
5. Alberti KGMM, Zimmett PZ, for the WHO Consultation: Definition, diagnosis and classification of diabetes mellitus and its complications. I. Diagnosis and classification of diabetes mellitus: provisional report of a WHO consultation. Diabet Med 15: 539-553, 1998
6. Harris MI, Eastman RC, Cowie CC, Flegal KM, Eberhardt MS: Comparison of diabetic diagnostic categories in the US population according to 1997 American Diabetes Association and 1980-1985 World Health Organization diagnostic criteria. Diabetes Care 20:1859-1862, 1997
7. Hanley AJG, Harris SB, Zinman B: Application of the revised American Diabetes Association criteria for the diagnosis of diabetes in a Canadian native population. Diabetes Care 21:870-871, 1998
8. Mannucci E, Bardini G, Ognibene A, Rotella C: Screening for diabetes in obese patients using the new diagnostic criteria. Diabetes Care 21:468, 1998
9. Shaw JE, de Courten MP, Hodge AM, McCarty D, Gareeboo H, Chitson P, Alberti KGMM, Zimmett PZ, on behalf of the Mauritius NCD Study Group: IGT or IFG for predicting NIDDM: who is right, WHO or ADA? (Abstract) Diabetologia. 41:A3, 1998
10. Barrett-Connor E, Ferrara A: Isolated post load hyperglycemia and the risk of fatal cardiovascular disease in older women and men: the Rancho Bernardo Study Diabetes Care 21:1236-1239, 1998
11. DECODE Study Group on behalf of the European Diabetes Epidemiology Study Group: Will new diagnostic criteria for diabetes mellitus change phenotype of patients with diabetes? Reanalysis of European epidemiological data. BMJ 317: 371-375, 1998
12. Hjelm M: Enzymatic determination of hexoses in blood and urine. Scand J Clin Lab Invest 18:85-88, 1996
13. SPSS: SPSS User's Guide. New York, McGraw Hill, 1986
14. Harris MI, Flegal KM, Cowie CC, Eberhardt MS, Goldstein ED, Little RR, Wiedmeyer HM, Byrd-Holt DD: Prevalence of diabetes, impaired fasting glucose, and IGT in U.S. adults. Diabetes Care 21:518-524, 1998
15. Ramachandran A, Snealatha C, Latha E, Vijay V: Evaluation of the use of fasting plasma glucose as a new diagnostic criterion for diabetes in Asian Indian population (Letter). Diabetes Care 21:666, 1998
16. Eldestein SL, Knowler WC, Bain RP, Andreas R, Barrett-Connor EL, Dowse GK, Haffner SM, Pettitt DJ, Sorkin JD, Muller DC, Collins VR, Hamman RF: Predictors of progression from IGT to NIDDM: an analysis of six prospective studies. Diabetes 46:701-710, 1997
17. Riccardi G, Vaccaro O, Rivellese A, Pignalosa S, Tutino L, Mancini M: Reproducibility of the new diagnostic criteria for IGT. Am J Epidemiol 121:422-429, 1985
18. Mooy JM, Gootenhuis PA, De Vries H, Kostense PJ, Poppsnyders C, Bouter LM, Heine RJ: Intra-individual variation of glucose, specific insulin and proinsulin concentrations measured by two oral glucose tolerance tests in the general Caucasian population: the Hoorn Study. Diabetologia 39:298-305, 1996
19. Sartor G, Schersten B, Carlstrom S, Melander A, Norden A, Persson G: Ten-year follow-up of subjects with impaired glucose tolerance: prevention of diabetes by tolbutamide and diet regulation. Diabetes 29:41-49, 1980
20. Keen H, Jarrett J, McCartney P: The ten-year follow-up of Bedford Survey (1962-1972): glucose tolerance and diabetes. Diabetologia 22:73-78, 1982
21. Eriksson KF, Lindgarde E: Prevention of type 2 (non insulin dependent) diabetes mellitus by diet and physical exercise: the 6-year Malmoe feasibility study. Diabetologia 34:891-898, 1991
22. Knowler WC, Narayan KMV, Hanson RL, Nelson RG, Bennett PH, Tuomiletho J, Schersten B, Pettitt D: Preventing non-insulin dependent diabetes. Diabetes 44:483-488, 1995
23. Pan XR, Li GW, Hu YH, Wang JX, Yang WY, An ZX, Hu ZX, Lin J, Xiao JZ, Cao HB, Liu PA, Jiang XG, Jiang YY, Wang JP, Zheng H, Zhang H, Bennett PH, Howard BV: Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance: the Da Qing IGT and Diabetes Study. Diabetes Care 20:537-544, 1997
24. Chiasson JL, Gomis R, Hanefeld M, Josse RJ, Karasik A, Laakso M: The STOP-NIDDM Trial Research Group: an international study on the efficacy of α-glucosidase inhibitor to prevent type 2 diabetes in a population with impaired glucose tolerance: rationale, design and preliminary screening data. Diabetes Care 21:1720-1725, 1998